Search research articles
Contact Us
Filters
Showing results (41-50 of 138) with videos related to
Page
of 14
Sort By:
Journal of Translational Medicine
|
December 16, 2014
Targeted cancer immunotherapy via combination of designer bispecific antibody and novel gene-engineered T cells
Katarzyna Urbanska, Rachel C Lynn, Caitlin Stashwick, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
May 16, 2008
Partial reduction of human FOXP3+ CD4 T cells in vivo after CD25-directed recombinant immunotoxin administration
Daniel J Powell, Peter Attia, Victor Ghetie, et al.
Oncoimmunology
|
July 30, 2013
IL-21 in cancer immunotherapy: At the right place at the right time
Saskia Jam Santegoets, Annelies W Turksma, Daniel J Powell, et al.
Journal of Hematology & Oncology
|
July 22, 2016
Effective adoptive immunotherapy of triple-negative breast cancer by folate receptor-alpha redirected CAR T cells is influenced by surface antigen expression level
De-Gang Song, Qunrui Ye, Mathilde Poussin, et al.
Blood
|
November 26, 2011
CD27 costimulation augments the survival and antitumor activity of redirected human T cells in vivo
De-Gang Song, Qunrui Ye, Mathilde Poussin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 1, 2011
Redirected antitumor activity of primary human lymphocytes transduced with a fully human anti-mesothelin chimeric receptor
Evripidis Lanitis, Mathilde Poussin, Ian S Hagemann, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
March 15, 2006
Selective elimination of human regulatory T lymphocytes in vitro with the recombinant immunotoxin LMB-2
Peter Attia, Daniel J Powell, Ajay V Maker, et al.
Cancer Immunology Research
|
January 11, 2014
Chimeric antigen receptor T Cells with dissociated signaling domains exhibit focused antitumor activity with reduced potential for toxicity in vivo
Evripidis Lanitis, Mathilde Poussin, Alex W Klattenhoff, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
January 2, 2007
Persistence of tumor infiltrating lymphocytes in adoptive immunotherapy correlates with telomere length
Xinglei Shen, Juhua Zhou, Karen S Hathcock, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 22, 2016
Tumor Regression and Delayed Onset Toxicity Following B7-H4 CAR T Cell Therapy
Jenessa B Smith, Evripidis Lanitis, Denarda Dangaj, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 138) with videos related to
Sort By:
Page
of 14
Journal of Translational Medicine
|
December 16, 2014
Targeted cancer immunotherapy via combination of designer bispecific antibody and novel gene-engineered T cells
Katarzyna Urbanska, Rachel C Lynn, Caitlin Stashwick, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
May 16, 2008
Partial reduction of human FOXP3+ CD4 T cells in vivo after CD25-directed recombinant immunotoxin administration
Daniel J Powell, Peter Attia, Victor Ghetie, et al.
Oncoimmunology
|
July 30, 2013
IL-21 in cancer immunotherapy: At the right place at the right time
Saskia Jam Santegoets, Annelies W Turksma, Daniel J Powell, et al.
Journal of Hematology & Oncology
|
July 22, 2016
Effective adoptive immunotherapy of triple-negative breast cancer by folate receptor-alpha redirected CAR T cells is influenced by surface antigen expression level
De-Gang Song, Qunrui Ye, Mathilde Poussin, et al.
Blood
|
November 26, 2011
CD27 costimulation augments the survival and antitumor activity of redirected human T cells in vivo
De-Gang Song, Qunrui Ye, Mathilde Poussin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 1, 2011
Redirected antitumor activity of primary human lymphocytes transduced with a fully human anti-mesothelin chimeric receptor
Evripidis Lanitis, Mathilde Poussin, Ian S Hagemann, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
March 15, 2006
Selective elimination of human regulatory T lymphocytes in vitro with the recombinant immunotoxin LMB-2
Peter Attia, Daniel J Powell, Ajay V Maker, et al.
Cancer Immunology Research
|
January 11, 2014
Chimeric antigen receptor T Cells with dissociated signaling domains exhibit focused antitumor activity with reduced potential for toxicity in vivo
Evripidis Lanitis, Mathilde Poussin, Alex W Klattenhoff, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
January 2, 2007
Persistence of tumor infiltrating lymphocytes in adoptive immunotherapy correlates with telomere length
Xinglei Shen, Juhua Zhou, Karen S Hathcock, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 22, 2016
Tumor Regression and Delayed Onset Toxicity Following B7-H4 CAR T Cell Therapy
Jenessa B Smith, Evripidis Lanitis, Denarda Dangaj, et al.
Page
of 14